Actively Recruiting
Mental Imagery and Targeted Memory Reactivation in Insomnia
Led by University Hospital, Geneva · Updated on 2026-03-03
120
Participants Needed
1
Research Sites
175 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Geneva
Lead Sponsor
U
University of Geneva, Switzerland
Collaborating Sponsor
AI-Summary
What this Trial Is About
In this clinical trial, the investigators test whether mental Imagery Rescripting (IR), a technique where the individual is instructed to transform a negative memory or image into a positive one, and olfactory Targeted Memory Reactivation (TMR), a technique used to strengthen memories, can reduce hyperarousal and insomnia severity in patients with Insomnia Disorder (ID). Patients with ID will be randomized into four groups: in the first group (SH group), patients will have 4 weekly sessions (1 session/week) of a minimal intervention for insomnia (sleep hygiene information) in the presence of an odorless diffuser, which will be also used during the night. In the second group (IR group), patients will use IR during wakefulness to induce a state of relaxation and positive emotionality. More specifically, during 4 weekly sessions of IR, patients will imagine a negative scenario related to their pre-sleep images or current concerns (e.g., social interactions, self-image, sleep problem, nightmares) and transform it into a positive script. They will then perform IR every day for 4 weeks at home in the presence of an odorless diffuser, which will be also used during the night. In the third group, patients will undergo the same 4 weekly IR sessions and an odor will be paired to the positive imagery and will be diffused during the night (TMR group). Patients from this group will also perform IR every day for 4 weeks at home. Finally, the fourth group (OA group) will receive 4 weekly sessions of sleep hygiene instructions in the presence of an odor, which will be also used during the night. Clinical evaluation of insomnia severity before and after the intervention will take place using the Insomnia Severity Index (ISI, primary outcome measure). At the end of these interventions, patients with persistent symptoms will benefit from an alternative experimental treatment ("rocking bed") in which they will be cradled for one night. The investigators hypothesize that patients treated with IR will have significantly reduced insomnia severity compared to participants who received a minimal intervention. They also hypothesize that patients of the TMR group, will have more reduced ID severity compared to participants performing IR and with an odorless diffuser, therefore without an association (IR group). Finally, they hypothesize that one night of sleeping in a rocking bed will improve objective measures of sleep in ID compared to a stationary condition.
CONDITIONS
Official Title
Mental Imagery and Targeted Memory Reactivation in Insomnia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 45 years
- Diagnosis of Insomnia Disorder according to the International Classification of Diseases 3 (ICSD-3)
- Insomnia Severity Index (ISI) score greater than 10
- Pittsburgh Sleep Quality Index (PSQI) score greater than 5
- Not currently receiving any treatment for insomnia
You will not qualify if you...
- Presence of another psychiatric disorder needing acute treatment according to DSM-5
- Medical or neurological disorders explaining insomnia symptoms (e.g., sleep apnea with oxygen desaturation index >15/h, restless legs syndrome, periodic limb movements >15, chronic pain)
- Significant substance use or withdrawal
- Heavy smoking
- Known pregnancy
- Problems with sense of smell, olfactory issues, or respiratory diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Center for Sleep Medicine
Geneva, Switzerland
Actively Recruiting
Research Team
L
Lampros Perogamvros
CONTACT
K
Kevin Mammeri
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here